In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alkermes applies ProLease to EPO for J&J; J&J ends deal

Executive Summary

Alkermes (drug delivery) will apply its ProLease injectable sustained release drug delivery technology to J&J division RW Johnson Pharmaceutical's erythropoietin for non-dialysis applications, in its third drug delivery deal with J&J.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies